Melvin Chiu is a Dermatology physician affiliated with University of Southern California. OpenAlex indexes 113 publications with 1,556 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1450 San Pablo St Ste 2000
Los Angeles, CA 900335331
Telephone
323-442-6200Provider last certified this registry record 21 Aug 2020.
Clinical trials
- Predictors of Patient Attitudes and Barriers to Skin Cancer Screening
Sponsor: Jonsson Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Deciphera Pharmaceuticals Inc.Program year20252 payments
- Tempus AI, IncProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
30.5%Corticosteroid15.8%Triamcinolone Acetonide66%Fluocinolone Acetonide34%Part D≥68 patientsInterleukin-4 Receptor alpha Antagonist9.7%Dupixent Pen88%Dupixent Syringe12%Part D<11 patients+ 2 more classes in this area
Anti-infectives
27.2%Azole Antifungal16.6%Ketoconazole100%Part D≥67 patientsTetracycline-class Drug3.9%Doxycycline Hyclate100%Part D≥14 patients+ 3 more classes in this area
Sensory organs
13.9%Corticosteroid11.6%Betamethasone Diprop Augmented45%Clobetasol Propionate36%Hydrocortisone20%Part D≥23 patientsSulfonamide Antibacterial2.4%Sulfacetamide Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Geospatial analysis of access to dermatology care in Los Angeles County: a cross sectional study
Dermatology Online Journal
2023 - Teledermatology: Meeting the Need for Specialized Care in Rural Haiti
Journal of Health Care for the Poor and Underserved
2019
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”